Top Medical Experts to Testify on Inadequate Federal Approach to Opioid Treatment and the Need to Expand Care

Jun 18, 2019
Press Release

 

Washington, D.C. (June 18, 2019)—On Wednesday, June 19, 2019, Rep. Elijah E. Cummings, the Chairman of the Committee on Oversight and Reform, will convene a third hearing on the opioid epidemic, entitled “Medical Experts:  Inadequate Federal Approach to Opioid Treatment and the Need to Expand Care.” 

 

The Committee will hear testimony from medical experts, including providers and a local public health official, regarding the inadequacy of the current federal approach to the opioid crisis and the need for increased evidence-based treatment for substance use disorder.

 

WHERE:  2154 Rayburn House Office Building

 

WHEN:  Wednesday, June 19, 2019

 

TIME:  10:00 a.m.

 

A livestream will broadcast here

 

PURPOSE

 

The hearing will examine:  (1) why so many patients and families in need of treatment are unable to obtain it; (2) whether the responses to date from the Executive Branch and

Congress have been adequate to address this generational crisis; and (3) H.R. 2569, the

Comprehensive Addiction Resources Emergency (CARE) Act, which is intended to increase

access to evidence-based treatment and wraparound services critical to supporting sustained

recovery.

 

BACKGROUND

 

  • For the entire first two years of the Trump Administration, the President failed to issue a National Drug Control Strategy, even though it is required by law.  Finally, this past January, the Administration released its first Strategy, but it failed to meet even the most basic requirements of the law.

 

  • A study based on the National Survey on Drug Use and Health found that “of the 19.9 million adults needing substance use treatment, 10.8 percent received specialty treatment.”

 

  • Last month, Chairman Cummings and Senator Elizabeth Warren introduced the Comprehensive Addiction Resources Emergency (CARE) Act—modeled directly on the bipartisan Ryan White Act, which Congress passed in 1990 to help state and local governments combat the HIV/AIDS epidemic—to provide the resources and the comprehensive framework to finally begin treating the opioid crisis like the critical public health emergency it is.

 

  • The CARE Act has been endorsed by more than 200 organizations, including the American Medical Association (AMA), the American Society of Addiction Medicine (ASAM), the American Psychological Association (APA), and National Nurses United.

 

  • This will be the third Committee hearing examining solutions to our country’s opioid epidemic.  The first hearing was held on March 7, 2019, and the second hearing was held on May 9, 2019.

 

WITNESSES

 

Susan R. Bailey, M.D.

President-elect

American Medical Association

 

Yngvild K. Olsen, M.D., MPH, DFASAM

Vice President, American Society of Addiction Medicine

Medical Director, Institutes for Behavior Resources Inc./REACH Health Services in Baltimore

 

Arthur C. Evans, Jr., Ph.D.

Chief Executive Officer/Executive Vice President

American Psychological Association

 

Jean Ross, RN

President

National Nurses United

 

Angela Gray, BSN, RN

Nurse Director

Berkeley-Morgan County Board of Health, West Virginia

 

###

116th Congress